Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 28, 2020; 26(32): 4817-4832
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4817
Table 3 The comparison of human leukocyte antigen alleles which increase or decrease the gastric cancer risk in gastric cancer subgroup cases in terms of CagA+ (≥ 2) EPIYA-C, n (%)
GC (≥ 2) EPIYA-C (n = 26, alleles = 52)GC (< 2) EPIYA-C (n = 18, alleles = 36)OR95%CIP value
MinimumMaximum
HLA-A*0212 (23)10 (27)0.780.292.060.6170
HLA-B*3512 (23)10 (27)0.780.292.060.6170
HLA-DRB1*1312 (23)12 (33)0.600.231.540.2903
HLA-DQA1*0124 (46)16 (44)1.070.452.510.8742
HLA-DQB1*0612 (23)16 (44)0.371.142.900.0369